$1000 Invested In Apellis Pharmaceuticals 5 Years Ago Would Be Worth This Much Today
Portfolio Pulse from Benzinga Insights
Over the past 5 years, Apellis Pharmaceuticals (NASDAQ:APLS) has outperformed the market with an annualized return of 36.83%, turning a $1000 investment into $5,101.77. The company now has a market cap of $7.76 billion.
February 05, 2024 | 6:30 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Apellis Pharmaceuticals has shown significant growth over the past 5 years, with a $1000 investment growing to $5,101.77.
The substantial return on investment over the past 5 years highlights Apellis Pharmaceuticals' strong performance and potential for future growth. This performance, significantly outpacing the market, suggests a positive outlook for the stock in the short term, especially considering its current market capitalization of $7.76 billion.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100